SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 75 filers reported holding SEELOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219 | -96.4% | 1,190 | -50.0% | 0.00% | – |
| Q2 2023 | $6,004 | +31.0% | 2,380 | +100.0% | 0.00% | – |
| Q1 2023 | $4,582 | +91540.0% | 1,190 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 1,190 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 1,190 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 1,190 | -50.0% | 0.00% | – |
| Q1 2022 | $10,000 | +400.0% | 2,380 | +100.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 1,190 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 1,190 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -50.0% | 1,190 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | – | 1,190 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |